USFDA issues OAI status to Sun Pharmaceutical Industries’ Dadra facility

12 Apr 2024 Evaluate

US Food and Drug Administration (USFDA) has issued Official Action Indicated (OAI) status to Sun Pharmaceutical Industries’ Dadra facility. USFDA conducted an inspection at Company’s Dadra facility from December 4, 2023 to December 15, 2023. The company will work with the regulator to achieve fully compliant status. 

Sun Pharmaceutical Industries is among the largest specialty generic pharmaceutical company and India's top pharmaceutical company.

Sun Pharma Inds. Share Price

1711.25 -8.50 (-0.49%)
01-Jan-2026 11:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1711.25
Dr. Reddys Lab 1254.10
Cipla 1503.00
Zydus Lifesciences 911.20
Lupin 2087.85
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×